SANOFI |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.23 EUR | -0.43% |
|
+4.99% | +1.64% |
| 04-26 | Sanofi to present advances at ATS in San Diego | CF |
| 04-25 | Health Care Drops Amid Mixed Earnings -- Health Care Roundup | DJ |
Chart calendar Sanofi
5a.YWYgr_b9VB44G253ZpXFMXtUom7ybMvhJSBa1dcDSMg.PhJ_nKHKZnhbelsgFcG_ZhAFkSKhB_PRekoRuZt7ALkrJW3GpKc7KwsqWg~90b7da5545b3228af6f4f30e9ad6c60f
Upcoming events on Sanofi
Past events on Sanofi
| 25/04/2024 13:30 | Q1 2024 Earnings Call |
| 25/04/2024 06:30 | Q1 2024 Earnings Release |
| 16/04/2024 | American Academy of Neurology Meeting |
| 13/03/2024 12:00 | Barclays Global Healthcare Conference |
| 12/03/2024 14:40 | Leerink Partners Global Biopharma Conference |
| 10/03/2024 20:30 | American Academy of Dermatology Meeting |
| 08/03/2024 22:50 | American Academy of Dermatology Meeting - Oral Presentation : 53782 |
| 08/03/2024 22:45 | American Academy of Dermatology Meeting - Oral Presentation : 53763 |
| 08/03/2024 19:30 | American Academy of Dermatology Meeting - Oral Presentation : 53710 |
| 08/03/2024 19:15 | American Academy of Dermatology Meeting - Oral Presentation : 53117 |
| 08/03/2024 18:55 | American Academy of Dermatology Meeting - Oral Presentation : 52680 |
| 08/03/2024 18:40 | American Academy of Dermatology Meeting - Oral Presentation : 52273 |
| 08/03/2024 16:55 | American Academy of Dermatology Meeting - Oral Presentation : 53907 |
| 08/03/2024 16:40 | American Academy of Dermatology Meeting - Oral Presentation : 53081 |
| 08/03/2024 16:30 | American Academy of Dermatology Meeting - Oral Presentation : 51363 |
| 07/03/2024 | American Academy of Dermatology Meeting - E Poster No : 51072 |
| 07/03/2024 | American Academy of Dermatology Meeting - E Poster No : 51598 |
| 07/03/2024 | American Academy of Dermatology Meeting - E Poster No : 52284 |
| 07/03/2024 | American Academy of Dermatology Meeting - E Poster No : 52842 |
| 07/03/2024 | American Academy of Dermatology Meeting - E Poster No : 50328 |
Past dividends on Sanofi
| 29/05/2023 | Annual 3.56 EUR |
| 05/05/2022 | Annual 3.33 EUR |
| 05/05/2022 | 0 EUR |
| 04/05/2021 | Annual 3.2 EUR |
| 03/05/2020 | Annual 3.15 EUR |
| 08/05/2019 | Annual 3.07 EUR |
| 10/05/2018 | Annual 3.03 EUR |
| 15/05/2017 | Annual 2.96 EUR |
| 09/05/2016 | Annual 2.93 EUR |
| 10/05/2015 | Annual 2.85 EUR |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 36 126 36 409 -0.78% | 36 041 36 401 -0.99% | 37 761 37 764 -0.01% | 42 997 43 479 -1.11% | 43 070 43 966 -2.04% | 45 989 |
|
EBITDA Million EUR | Released Forecast Spread | 11 904 11 227 6.03% | 11 443 11 341 0.9% | 12 183 11 787 3.36% | 14 627 14 574 0.36% | 14 259 13 722 3.91% | 13 675 |
|
EBIT Million EUR | Released Forecast Spread | 9 758 9 632 1.31% | 9 762 9 684 0.8% | 10 714 10 631 0.78% | 13 040 12 965 0.58% | 12 670 12 363 2.48% | 12 443 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 2 822 4 093 -31.06% | 13 804 11 524 19.79% | 7 798 7 790 0.1% | 8 268 8 304 -0.44% | 7 038 9 458 -25.59% | 9 011 |
|
Net income Million EUR | Released Forecast Spread | 2 806 3 910 -28.23% | 12 314 12 136 1.47% | 6 223 6 161 1.01% | 6 720 7 446 -9.75% | 5 400 7 748 -30.31% | 6 860 |
|
EPS EUR | Released Forecast Spread | 2,24 3,02 -25.75% | 9,82 9,68 1.44% | 4,97 4,91 1.31% | 5,37 5,86 -8.39% | 4,31 6,19 -30.32% | 5,55 |
| Announcement Date | 06/02/20 | 05/02/21 | 04/02/22 | 03/02/23 | 01/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million EUR | Released Forecast Spread | 9 994 10 098 -1.03% | 9 674 9 271 4.35% | 10 116 9 830 2.91% | 12 482 12 045 3.63% | 10 725 10 970 -2.23% | 10 222 10 288 -0.65% | 9 965 10 072 -1.06% | 11 964 12 016 -0.44% | 10 919 10 989 -0.64% | 10 464 10 208 2.51% | 10 501 | 13 023 | 11 778 | 10 805 |
|
EBITDA Million EUR | Released Forecast Spread | 2 623 2 092 25.4% | 3 426 3 116 9.93% | 3 163 2 953 7.13% | 4 931 4 615 6.84% | 3 107 3 009 3.26% | 3 703 3 799 -2.54% | 3 087 3 008 2.64% | 4 460 4 103 8.71% | 3 009 2 863 5.11% | 3 192 2 991 6.73% | 2 705 | 4 327 | 2 628 | |
|
EBIT Million EUR | Released Forecast Spread | 2 256 2 238 0.8% | 3 065 2 840 7.94% | 2 753 2 621 5.04% | 4 498 4 261 5.56% | 2 724 2 721 0.11% | 3 333 3 225 3.35% | 2 726 2 636 3.42% | 4 028 4 145 -2.82% | 2 583 2 714 -4.81% | 2 843 2 680 6.07% | 2 554 | 4 186 | 2 842 | 3 045 |
|
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | 1 391 1 302 6.84% | 2 349 1 966 19.48% | 1 383 1 771 -21.91% | 2 666 4 517 -40.98% | 1 921 2 228 -13.78% | 2 468 2 335 5.7% | 1 718 1 845 -6.88% | 2 971 3 504 -15.21% | -249 2 408 -110.34% | 1 310 1 829 -28.38% | 1 827 | 3 635 | 2 303 | |
|
Net income Million EUR | Released Forecast Spread | 1 131 1 195 -5.34% | 2 009 1 790 12.25% | 1 175 1 637 -28.21% | 2 076 3 769 -44.91% | 1 460 2 193 -33.41% | 1 995 1 877 6.27% | 1 435 1 496 -4.05% | 2 525 2 648 -4.64% | -555 1 592 -134.85% | 1 133 1 601 -29.24% | 1 467 | 2 795 | 1 660 | |
|
EPS EUR | Released Forecast Spread | 0,90 0,90 0.13% | 1,61 1,45 11.06% | 0,94 1,28 -26.48% | 1,66 3,04 -45.33% | 1,16 1,67 -30.35% | 1,60 1,50 6.86% | 1,15 1,20 -3.77% | 2,01 2,10 -4.38% | -0,44 1,27 -134.75% | 0,91 1,28 -28.71% | 1,17 | 2,22 | 1,32 | |
| Announcement Date | 04/02/22 | 28/04/22 | 28/07/22 | 28/10/22 | 03/02/23 | 27/04/23 | 28/07/23 | 27/10/23 | 01/02/24 | 25/04/24 | - | - | - | - |
More events
Past sector events for Sanofi
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SAN Stock
- Calendar Sanofi
